SARS-CoV-2
Research Article | Clinical Science and EpidemiologyA Genome Epidemiological Study of SARS-CoV-2 Introduction into JapanThis study aimed to evaluate the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genome sequences from COVID-19 cases and to characterize their genealogical networks to demonstrate possible routes of spread in Japan. We found that there were at least two distinct SARS-CoV-2 introductions into Japan, initially from China and subsequently from other countries, including Europe. Our findings can help understand how SARS-CoV-2...
Research Article | Clinical Science and EpidemiologyDaily Viral Kinetics and Innate and Adaptive Immune Response Assessment in COVID-19: a Case SeriesThis work is particularly important because it simultaneously assessed the virology, immunology, and clinical presentation of the same subjects, whereas other studies assess these separately. We describe the detailed viral and immune profiles of the first five patients infected by SARS-CoV-2 and quarantined in Geneva, Switzerland. Viral loads peaked at the very beginning of the disease, and infectious virus was shed only during the...
Observation | Clinical Science and EpidemiologyEffectiveness of Face Masks in Preventing Airborne Transmission of SARS-CoV-2Airborne simulation experiments showed that cotton masks, surgical masks, and N95 masks provide some protection from the transmission of infective SARS-CoV-2 droplets/aerosols; however, medical masks (surgical masks and even N95 masks) could not completely block the transmission of virus droplets/aerosols even when sealed.
Editor's Pick Commentary | Clinical Science and EpidemiologymSphere of Influence: That’s Racist—COVID-19, Biological Determinism, and the Limits of HypothesesKishana Taylor works in the field of virology. In this mSphere of Influence article, she reflects on the personal impact of “Racial health disparities and COVID-19 – caution and context” by Merlin Chowkwanyun and Adolph L. Reed, Jr. (N Engl J Med 383:201–203, 2020, https://doi.org/10.1056/NEJMp2012910) and “A hypothesis is a liability” by Itai Yanai and Martin Lercher (Genome Biol 21:...
Research Article | Clinical Science and EpidemiologyCompetitive SARS-CoV-2 Serology Reveals Most Antibodies Targeting the Spike Receptor-Binding Domain Compete for ACE2 BindingWith the emergence and continued spread of the SARS-CoV-2 virus, and of the associated disease, coronavirus disease 2019 (COVID-19), there is an urgent need for improved understanding of how the body mounts an immune response to the virus. Here, we developed a competitive SARS-CoV-2 serological assay that can simultaneously determine whether an individual has developed antibodies against the SARS-CoV-2 Spike protein receptor-binding...
Editor's Pick Research Article | Therapeutics and PreventionEvolution of Early SARS-CoV-2 and Cross-Coronavirus ImmunityA critical step to ending the spread of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the ability to detect, diagnose, and understand why some individuals develop mild and others develop severe disease. For example, defining the early evolutionary patterns of humoral immunity to SARS-CoV-2, and whether prevalent coronaviruses or other common infections influence the evolution of immunity, remains poorly...
Observation | Host-Microbe BiologyA Simplified Quantitative Real-Time PCR Assay for Monitoring SARS-CoV-2 Growth in Cell CultureSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the etiological agent of the coronavirus disease 2019 (COVID-19) pandemic, is continuing to cause immense respiratory disease and social and economic disruptions. Conventional assays that monitor SARS-CoV-2 growth in cell culture rely on costly and time-consuming RNA extraction procedures, hampering progress in basic SARS-CoV-2 research and development of effective...
Research Article | Clinical Science and EpidemiologyDevelopment and Clinical Application of a Rapid and Sensitive Loop-Mediated Isothermal Amplification Test for SARS-CoV-2 InfectionWe developed a visual and rapid reverse transcription–loop-mediated isothermal amplification (RT-LAMP) assay targeting the S gene for SARS-CoV-2 infection. The strength of our study was that we validated the RT-LAMP assay using 481 clinical respiratory samples from two prospective cohorts of suspected COVID-19 patients and on the serial samples from an asymptomatic carrier. The developed RT-LAMP approach showed an increased...
Research Article | Clinical Science and EpidemiologyClinical Characteristics and Immune Injury Mechanisms in 71 Patients with COVID-19The dysregulation of CD3+ CD8+ T lymphocytes, CD16+ CD56+ NK cells, C1q as well as IL-6, along with bacterial coinfection, were important causes of exacerbation of the patients’ condition and death.
Editor's Pick Observation | Applied and Environmental ScienceIncreasing Temperature and Relative Humidity Accelerates Inactivation of SARS-CoV-2 on SurfacesMitigating the transmission of SARS-CoV-2 in clinical settings and public spaces is critically important to reduce the number of COVID-19 cases while effective vaccines and therapeutics are under development. SARS-CoV-2 transmission is thought to primarily occur through direct person-to-person transfer of infectious respiratory droplets or through aerosol-generating medical procedures. However, contact with contaminated surfaces may...